CLRB ▼ -0.8% - Cellectar Biosciences, Inc.
$CLRB CLRBW CLRBZ - Cellectar Biosciences to Present Three Posters Highlighting Durable Clinical Activity of Iopofosine I 131 in Waldenström Macroglobulinemia at the American Society of Hematology Annual Meeting and Exposition
04-NOV-2026 09:00 AM ET
Share this post
More filings for $CLRB
CLRB ▲ +2.5% - Cellectar Biosciences, Inc.Nov 2, 2026CLRB ▲ +4.9% - Cellectar Biosciences, Inc.Oct 27, 2026CLRB ▲ +6.7% - Cellectar Biosciences, Inc.Oct 15, 2026CLRB ▲ +0.5% - Cellectar Biosciences, Inc.Sep 29, 2026CLRB - Cellectar Biosciences, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026CLRB - Cellectar Biosciences, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $CLRB filing history →💬 Comments
Loading comments…
Leave a comment